"SARS-CoV-2" の関連情報検索結果
News
Q&A
Shopping
Auction
Rakuten
amazonNeurological and neurodevelopmental effects of Covid and MIS-C on children - Nature
Neurological and neurodevelopmental effects of Covid and MIS-C on children Nature
Prior exposure to cold viruses boosts antibody response against SARS-CoV-2 - News-Medical
Prior exposure to cold viruses boosts antibody response against SARS-CoV-2 News-Medical
National COVID-19 trends, November 11 - The Sick Times
National COVID-19 trends, November 11 The Sick Times
SARS-CoV-2 variants: biology, pathogenicity, immunity and control - Nature
SARS-CoV-2 variants: biology, pathogenicity, immunity and control Nature
The European Respiratory Virus Surveillance Summary (ERVISS) - European Centre for Disease Preven...
The European Respiratory Virus Surveillance Summary (ERVISS) European Centre for Disease Prevention and Control
2024-25 COVID-19 Vaccines Effective Against JN1 Subvariants - Contagion Live
2024-25 COVID-19 Vaccines Effective Against JN1 Subvariants Contagion Live
SARS-CoV-2 nucleocapsid protein directly prevents cGAS–DNA recognition through competitive bindin...
SARS-CoV-2 nucleocapsid protein directly prevents cGAS–DNA recognition through competitive binding PNAS
Four million COVID-19 cases in four European cross-border regions reveal minimal cross-border tra...
Four million COVID-19 cases in four European cross-border regions reveal minimal cross-border transmission effect on domestic burden: space-time cluster analysis BMC Infectious Diseases
Evolution of SARS-CoV-2 T cell responses as a function of multiple COVID-19 boosters - ScienceDir...
Evolution of SARS-CoV-2 T cell responses as a function of multiple COVID-19 boosters ScienceDirect.com
Mass production of IgY-containing tablets for COVID-19 transmission control - Nature
Mass production of IgY-containing tablets for COVID-19 transmission control Nature
SARS-CoV-2 nsp15 enhances viral virulence by subverting host antiviral defenses - PNAS
SARS-CoV-2 nsp15 enhances viral virulence by subverting host antiviral defenses PNAS
Communicable disease threats report, 1-7 November 2025, week 45 - European Centre for Disease Pre...
Communicable disease threats report, 1-7 November 2025, week 45 European Centre for Disease Prevention and Control
SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade - Nature
SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade Nature
Optimizing the schedule of BNT162b2 COVID-19 against long COVID and associated quality of life lo...
Gut infection and dysbiosis are hallmarks of severe SARS-CoV-2 variants - Nature
Gut infection and dysbiosis are hallmarks of severe SARS-CoV-2 variants Nature
Phosphorylation toggles the SARS-CoV-2 nucleocapsid protein between two membrane-associated conde...
SARS-CoV-2 NSP14 inhibitor exhibits potent antiviral activity and reverses NSP14-driven host modu...
Paternal SARS-CoV-2 infection impacts sperm small noncoding RNAs and increases anxiety in offspri...
Association of SARS-CoV-2 vaccination status with risk of influenza-like illness and loss of work...
exposure and COVID19-related hospitalizations in the National Clinical Cohort Collaborative - Nature
exposure and COVID19-related hospitalizations in the National Clinical Cohort Collaborative Nature
Long COVID associated with SARS-CoV-2 reinfection among children and adolescents in the omicron e...
SARS-CoV-2 Causes Buildup of Alzheimer’s-Related Peptides in the Retina - Yale School of Medicine
SARS-CoV-2 Causes Buildup of Alzheimer’s-Related Peptides in the Retina Yale School of Medicine
Could this Molecule be ‘Checkmate’ for Coronaviruses like SARS-CoV-2? - UC San Francisco
Could this Molecule be ‘Checkmate’ for Coronaviruses like SARS-CoV-2? UC San Francisco
SARS-CoV-2 variants retain high airborne transmissibility by different strategies | npj Viruses -...
SARS-CoV-2 variants retain high airborne transmissibility by different strategies | npj Viruses Nature
COVID-19 Treatment Clinical Care for Outpatients - Centers for Disease Control and Prevention | C...
COVID-19 Treatment Clinical Care for Outpatients Centers for Disease Control and Prevention | CDC (.gov)
ACAAI: COVID-19 Vaccination Reduces Risk for Multiple Infections in Children With Atopic Dermatit...
ACAAI: COVID-19 Vaccination Reduces Risk for Multiple Infections in Children With Atopic Dermatitis Optometry Advisor
COVID-19 | Yellow Book - Centers for Disease Control and Prevention | CDC (.gov)
COVID-19 | Yellow Book Centers for Disease Control and Prevention | CDC (.gov)
Study Shows SARS-CoV-2 Corrupts Some White Blood Cells to Suppress Immune System, Suggesting a Pa...
Study Shows SARS-CoV-2 Corrupts Some White Blood Cells to Suppress Immune System, Suggesting a Path to Severe COVID Johns Hopkins Medicine
WHO Scientific advisory group issues report on origins of COVID-19 - World Health Organization (WHO)
WHO Scientific advisory group issues report on origins of COVID-19 World Health Organization (WHO)
Burden of Cardiovascular Outcomes After SARS-CoV-2 Infection in South Korea and Japan: A Bination...
Burden of Cardiovascular Outcomes After SARS-CoV-2 Infection in South Korea and Japan: A Binational Population-Based Cohort Study | Circulation American Heart Association Journals
Dynavax pays Vaxart $30M for oral COVID-19 vaccine program - Fierce Biotech
Dynavax pays Vaxart $30M for oral COVID-19 vaccine program Fierce Biotech
Sulfonohydrazide as a potential inhibitor of SARS-CoV-2 infection - Nature
Sulfonohydrazide as a potential inhibitor of SARS-CoV-2 infection Nature
COVID Is Beginning to Surge Globally. Here’s What We Know - Scientific American
COVID Is Beginning to Surge Globally. Here’s What We Know Scientific American
Human ACE2 transgenic pigs are susceptible to SARS-CoV-2 and develop COVID-19-like disease - Nature
Human ACE2 transgenic pigs are susceptible to SARS-CoV-2 and develop COVID-19-like disease Nature
A predictive language model for SARS-CoV-2 evolution - Nature
SARS-CoV-2 compromises blastocyst quality by modifying the ovarian microenvironment - Nature
SARS-CoV-2 compromises blastocyst quality by modifying the ovarian microenvironment Nature
SARS-CoV-2 Vaccines and Multiple Sclerosis - Neurology® Journals
SARS-CoV-2 Vaccines and Multiple Sclerosis Neurology® Journals
Inferring effects of mutations on SARS-CoV-2 transmission from genomic surveillance data - Nature
Inferring effects of mutations on SARS-CoV-2 transmission from genomic surveillance data Nature
Women are three times more likely than men to get severe long COVID: Here’s why - University of A...
Women are three times more likely than men to get severe long COVID: Here’s why University of Alberta
[6]-Shogaol Inhibits 3CLpro and SARS-CoV-2 Infection - Bioengineer.org
[6]-Shogaol Inhibits 3CLpro and SARS-CoV-2 Infection Bioengineer.org
Targeting the SARS-CoV-2 reservoir in long COVID - The Lancet
The comprehensive SARS-CoV-2 ‘hijackome’ knowledge base - Cell Discovery - Nature
The comprehensive SARS-CoV-2 ‘hijackome’ knowledge base - Cell Discovery Nature
Phenotypic evolution of SARS-CoV-2 spike during the COVID-19 pandemic - Nature
Phenotypic evolution of SARS-CoV-2 spike during the COVID-19 pandemic Nature
Vaccines, infections and chronic diseases: A new understanding - World Socialist Web Site
Vaccines, infections and chronic diseases: A new understanding World Socialist Web Site
Emergence and spread of the SARS-CoV-2 omicron (BA.1) variant across Africa: an observational stu...
Emergence and spread of the SARS-CoV-2 omicron (BA.1) variant across Africa: an observational study The Lancet
Mutated epitopes in SARS-CoV-2 variants are poorly immunogenic - Nature
Mutated epitopes in SARS-CoV-2 variants are poorly immunogenic Nature
Lab Leak: The True Origins of Covid-19 - The White House (.gov)
Lab Leak: The True Origins of Covid-19 The White House (.gov)
The SARS-CoV-2 test scale-up in the USA: an analysis of the number of tests produced and used ove...
No-Needle Test Can Tell if Flu/COVID Vaccines Are Effective | Newswise - Newswise
No-Needle Test Can Tell if Flu/COVID Vaccines Are Effective | Newswise Newswise
Aligos and KU Leuven divulge new antivirals - BioWorld MedTech
Aligos and KU Leuven divulge new antivirals BioWorld MedTech
Quantitative IgG response to SARS-CoV-2 membrane protein in infected individuals strongly correla...
Assessing SARS-CoV-2 Virus Levels in Sewage - U.S. Environmental Protection Agency (.gov)
Assessing SARS-CoV-2 Virus Levels in Sewage U.S. Environmental Protection Agency (.gov)
How lab-grown ‘lungs’ are helping fight infectious diseases - Technology Org
How lab-grown ‘lungs’ are helping fight infectious diseases Technology Org
Researchers Find New Corona Virus Variants In Brazil In Bat Species - VOI.ID
Researchers Find New Corona Virus Variants In Brazil In Bat Species VOI.ID
The consequences of SARS-CoV-2 within-host persistence - Nature
The consequences of SARS-CoV-2 within-host persistence Nature
‘Covid-19 is still a force to be reckoned with’: Why medical experts recommend up-to-date protect...
‘Covid-19 is still a force to be reckoned with’: Why medical experts recommend up-to-date protection The Straits Times
Chairman Dr. Rand Paul, M.D. Seeks Intelligence Community Records Related to COVID Origins - Smal...
Chairman Dr. Rand Paul, M.D. Seeks Intelligence Community Records Related to COVID Origins Small Wars Journal
Characteristics of SARS-CoV-2 and COVID-19 - Nature
Coronavirus Disease 2019 (COVID-19) - Centers for Disease Control and Prevention | CDC (.gov)
Coronavirus Disease 2019 (COVID-19) Centers for Disease Control and Prevention | CDC (.gov)
The species Severe acute respiratory syndrome-related coronavirus : classifying 2019-nCoV and nam...
The proximal origin of SARS-CoV-2 - Nature
Transmission of SARS-CoV-2: implications for infection prevention precautions - World Health Orga...
Transmission of SARS-CoV-2: implications for infection prevention precautions World Health Organization (WHO)
Activity of Research-Grade Pemivibart against Recent SARS-CoV-2 JN.1 Sublineages - The New Englan...
Activity of Research-Grade Pemivibart against Recent SARS-CoV-2 JN.1 Sublineages The New England Journal of Medicine
Tracking SARS-CoV-2 variants - World Health Organization (WHO)
Tracking SARS-CoV-2 variants World Health Organization (WHO)
Surveillance and Data Analytics | COVID-19 - Centers for Disease Control and Prevention | CDC (.gov)
Surveillance and Data Analytics | COVID-19 Centers for Disease Control and Prevention | CDC (.gov)
Acute and postacute sequelae associated with SARS-CoV-2 reinfection - Nature
Acute and postacute sequelae associated with SARS-CoV-2 reinfection Nature
SARS-CoV-2 infection and persistence in the human body and brain at autopsy - Nature
SARS-CoV-2 infection and persistence in the human body and brain at autopsy Nature
SARS-CoV-2 infection triggers pro-atherogenic inflammatory responses in human coronary vessels - ...
SARS-CoV-2 infection triggers pro-atherogenic inflammatory responses in human coronary vessels Nature
SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC) - Nature
SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC) Nature
Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern - World Health Organization ...
Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern World Health Organization (WHO)
The evolution of SARS-CoV-2 - Nature
The evolution of SARS-CoV-2 Nature
Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1 - The New England Journal...
Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1 The New England Journal of Medicine
About COVID-19 - Centers for Disease Control and Prevention | CDC (.gov)
About COVID-19 Centers for Disease Control and Prevention | CDC (.gov)
WHO-convened global study of origins of SARS-CoV-2: China Part - World Health Organization (WHO)
WHO-convened global study of origins of SARS-CoV-2: China Part World Health Organization (WHO)
How lung distress from SARS-CoV-2 can cause heart damage - National Institutes of Health (.gov)
How lung distress from SARS-CoV-2 can cause heart damage National Institutes of Health (.gov)
Laboratory biosafety guidance related to SARS-CoV-2 (COVID-19): Interim guidance, 11 March 2024 -...
Laboratory biosafety guidance related to SARS-CoV-2 (COVID-19): Interim guidance, 11 March 2024 World Health Organization (WHO)
SARS-CoV-2 productively infects human gut enterocytes - Science | AAAS
SARS-CoV-2 productively infects human gut enterocytes Science | AAAS
Long COVID after breakthrough SARS-CoV-2 infection - Nature
Reducing transmission of SARS-CoV-2 - Science | AAAS
Reducing transmission of SARS-CoV-2 Science | AAAS
SARS-CoV-2 Infection in Children - The New England Journal of Medicine
SARS-CoV-2 Infection in Children The New England Journal of Medicine
Human SARS-CoV-2 challenge uncovers local and systemic response dynamics - Nature
Human SARS-CoV-2 challenge uncovers local and systemic response dynamics Nature
Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2 - Nature
Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2 Nature
Postacute Sequelae of SARS-CoV-2 Infection in the Pre-Delta, Delta, and Omicron Eras - The New En...
Postacute Sequelae of SARS-CoV-2 Infection in the Pre-Delta, Delta, and Omicron Eras The New England Journal of Medicine
Coronavirus disease (COVID-19) - World Health Organization (WHO)
Coronavirus disease (COVID-19) World Health Organization (WHO)
Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults - Nature
Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults Nature
SARS-CoV-2 variants, spike mutations and immune escape - Nature
SARS-CoV-2 variants, spike mutations and immune escape Nature
SARS-CoV-2 infection of the oral cavity and saliva - Nature
Joint statement on the prioritization of monitoring SARS-CoV-2 infection in wildlife and preventi...
Joint statement on the prioritization of monitoring SARS-CoV-2 infection in wildlife and preventing the formation of animal reservoirs World Health Organization (WHO)
SARS-CoV-2 vaccines in development - Nature
The coding capacity of SARS-CoV-2 - Nature
SARS-CoV-2 evolution during treatment of chronic infection - Nature
SARS-CoV-2 evolution during treatment of chronic infection Nature
SARS-CoV-2 in Animals - aphis.usda.gov
SARS-CoV-2 in Animals aphis.usda.gov
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls - Nature
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls Nature
Effect of Vaccination on Household Transmission of SARS-CoV-2 in England - The New England Journa...
Effect of Vaccination on Household Transmission of SARS-CoV-2 in England The New England Journal of Medicine
SARS-CoV-2 spreads through cell-to-cell transmission - PNAS
A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection - Nature
A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection Nature
SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients - The New England Journ...
SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients The New England Journal of Medicine
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host - The New England Journal of...
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host The New England Journal of Medicine
SARS-CoV-2 can cause lasting damage to cells' energy production - National Institutes of Health (...
SARS-CoV-2 can cause lasting damage to cells' energy production National Institutes of Health (.gov)
The molecular epidemiology of multiple zoonotic origins of SARS-CoV-2 - Science | AAAS
The molecular epidemiology of multiple zoonotic origins of SARS-CoV-2 Science | AAAS